Back
ESC Premium Access

Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

Session: Poster session 1 - Treatment of dyslipidaemia
Topic: Drug therapy
Speaker: Professor A. Shek (Tashkent, UZ)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Aleksandr Shek

Specialized Cardiology Center of the Republic of Uzbekistan, Tashkent (Uzbekistan)
0 follower

3 more presentations in this session

Treatment and control of dyslipidemia among adults in northeastern China: results of the dyslipidemia international study (DYSIS)

Speaker: Doctor W. Zheng (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Anti-proprotein convertase subtilisin-kexin type 9 monoclonal antibodies: effects on lipid profile and arterial stiffness

Access
Like
Thumbnail

Evaluation of statin users, people with hypercholesterolemia, and cardiovascular disease patients in the Japan Medical Data Center claims database

Speaker: Doctor K. Monda (Thousand Oaks, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 1 - Treatment of dyslipidaemia

Speakers: Professor A. Shek, Doctor W. Zheng, Doctor K. Monda
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources